Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target
- Supplementary File 1:
ZIP-Document (ZIP, 1449 KiB)
Jung, H.; Bae, K.; Lee, J.Y.; Kim, J.-H.; Han, H.-J.; Yoon, H.-Y.; Yoon, K.-A. Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target. Int. J. Mol. Sci. 2021, 22, 9151. https://doi.org/10.3390/ijms22179151
Jung H, Bae K, Lee JY, Kim J-H, Han H-J, Yoon H-Y, Yoon K-A. Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target. International Journal of Molecular Sciences. 2021; 22(17):9151. https://doi.org/10.3390/ijms22179151
Chicago/Turabian StyleJung, Hyojik, Kieun Bae, Ja Young Lee, Jung-Hyun Kim, Hyun-Jung Han, Hun-Young Yoon, and Kyong-Ah Yoon. 2021. "Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target" International Journal of Molecular Sciences 22, no. 17: 9151. https://doi.org/10.3390/ijms22179151